{"database":"biostudies-other","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24"],"submitter":["Johannes Meyer"],"journal":["Clinical cancer research : an official journal of the American Association for Cancer Research"],"pagination":["3325-3333"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/MODEL1909050002"],"repository":["biostudies-other"],"additional_accession":["29463551"],"pubmed_authors":["Johannes Meyer"]},"is_claimable":false,"name":"Ribba2018 - Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy","description":"

This is a model developed to predict concentrations of cergutuzumab amunaleukin (CEA-IL2v) after various systemic dosing intensities.

","dates":{"release":"2019-09-05T00:00:00Z","modification":"2025-07-14T17:47:38.778Z","creation":"2025-03-30T22:48:08.387Z"},"accession":"MODEL1909050002","cross_references":{"pubmed":["29463551"],"ncit":["C141459"],"mamo":["MAMO_0000046"],"doi":["10.1158/1078-0432.CCR-17-2953"]}}